The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Reasoning
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Cite this ruling
CBP Ruling N316489 (2933798500): The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293379
The tariff classification of Indacaterol Base (CAS No. 312753-06-3) in bulk powder form, from Spain
The tariff classification of Apixaban (CAS No. 503612-47-3) in bulk powder form, from Spain
The tariff classification of Benazepril Hydrochloride (CAS No. 86541-74-4) in bulk powder form, from Spain
The tariff classification of Nintedanib Esylate (CAS No. 656247-18-6) in bulk powder form, from Finland
The tariff classification of Aripiprazole Lauroxil (CAS No. 1259305-29-7) in bulk form, from Spain. Correction to Ruling Number N289285